EXUMA Trademark

Trademark Overview


On Thursday, August 11, 2022, a trademark application was filed for EXUMA with the United States Patent and Trademark Office. The USPTO has given the EXUMA trademark a serial number of 97544808. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, November 6, 2024. This trademark is owned by Exuma Biotech Corp.. The EXUMA trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacturing of medical products in the nature of biological tissue, blood, viruses, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy, including gene therapy, CAR T cell therapy, and cell therapy; custom manufacturing of biological preparations for the treatment of cancer

Medicines for human purposes in the nature of pharmaceutical preparations for gene and cell therapy, immunotherapy and the treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, and infectious diseases; biological preparations for medical treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, gene and cell therapy, and infectious diseases for humans and animals; medical biological tissue cultures and viruses for the prevention and treatment of cancer for humans and animals; drug products in the nature of pharmaceutical preparations for immunotherapy and the treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, and infectious diseases for humans and animals

Bacteriological research; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research; virological research; medical laboratory services; scientific research; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs, namely, processing blood to isolate leukocytes for the creation of immunotherapies; scientific and medical research and development of pharmaceutical preparations and drugs; computer programming in relation to medicine and medical research; research in the field of stem cells
exuma

General Information


Serial Number97544808
Word MarkEXUMA
Filing DateThursday, August 11, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, November 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesCustom manufacturing of medical products in the nature of biological tissue, blood, viruses, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy, including gene therapy, CAR T cell therapy, and cell therapy; custom manufacturing of biological preparations for the treatment of cancer
Goods and ServicesMedicines for human purposes in the nature of pharmaceutical preparations for gene and cell therapy, immunotherapy and the treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, and infectious diseases; biological preparations for medical treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, gene and cell therapy, and infectious diseases for humans and animals; medical biological tissue cultures and viruses for the prevention and treatment of cancer for humans and animals; drug products in the nature of pharmaceutical preparations for immunotherapy and the treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, and infectious diseases for humans and animals
Goods and ServicesBacteriological research; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research; virological research; medical laboratory services; scientific research; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs, namely, processing blood to isolate leukocytes for the creation of immunotherapies; scientific and medical research and development of pharmaceutical preparations and drugs; computer programming in relation to medicine and medical research; research in the field of stem cells

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, August 31, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 31, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameExuma Biotech Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Palm Beach, FL 33401

Party NameExuma Biotech Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Palm Beach, FL 33401

Trademark Events


Event DateEvent Description
Monday, August 15, 2022NEW APPLICATION ENTERED
Wednesday, August 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 31, 2023ASSIGNED TO EXAMINER
Friday, June 2, 2023NON-FINAL ACTION WRITTEN
Friday, June 2, 2023NON-FINAL ACTION E-MAILED
Friday, June 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 1, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, September 1, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, December 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 6, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 16, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, February 5, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, February 5, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, February 5, 2024EXAMINERS AMENDMENT E-MAILED
Monday, February 5, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 5, 2024EXAMINER'S AMENDMENT ENTERED
Monday, February 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 6, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2024SOU EXTENSION 1 GRANTED
Wednesday, November 6, 2024SOU EXTENSION 1 FILED